The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection.
| Author | |
|---|---|
| Abstract |
:
Genotype 1b (GT1b) is the most common subtype of the hepatitis C virus (HCV). We present an integrated analysis of 1070 participants with HCV GT1b infection from 30 countries who received elbasvir/grazoprevir for 12 weeks. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of gastroenterology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0944-1174
|
| URL |
:
https://dx.doi.org/10.1007/s00535-018-1429-3
|
| DOI |
:
10.1007/s00535-018-1429-3
|
| Short Title |
:
J Gastroenterol
|
| Download citation |
